Market Forecast News: Nuclear Medicine Software to Hit $1,491.55M by 2030
Summary
The report projects that the global nuclear medicine software market will rise from USD 970.03 million in 2025 to USD 1,491.55 million by 2030. It highlights growth drivers such as chronic disease prevalence, automation, cloud deployment, and investment in advanced imaging and personalized therapies. It also notes key restraints, including security concerns, AI training data gaps, interoperability issues, and limited healthcare infrastructure. The diagnostics segment leads the market, while pharmaceutical and biotech companies represent the fastest-growing end-user group because of theranostics and radiopharmaceutical R&D. North America remains the largest regional market, supported by strong imaging adoption, reimbursement frameworks, and a dense installed base of PET and SPECT systems.
Classifications
AskAI Classifications
LabelsLinked Companies
